zcela výstup Pozoruhodný cd105 marker proč Definitivní ty jsi
IJMS | Free Full-Text | Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential - ScienceDirect
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy
IJMS | Free Full-Text | Adult Stem Cell Functioning in the Tumor Micro-Environment
Prospective isolation of human bone marrow stromal cell subsets: A comparative study between Stro-1-, CD146- and CD105-enriched populations - David Gothard, Joanna Greenhough, Esther Ralph, Richard OC Oreffo, 2014
A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma | Molecular Cancer | Full Text
Anti-Endoglin / CD105 (Angiogenesis Marker) ENG Monoclonal Antibody
CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma | SpringerLink
Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta | Haematologica
Expression of CD105 surface marker by EA.hy926 endothelial cells (1),... | Download Scientific Diagram
CD105 (Endoglin) as negative prognostic factor in AML | Scientific Reports
CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients | PLOS ONE
Endothelial and hematopoietic marker analysis of CD105 positive cells... | Download Scientific Diagram